Department of Chemistry, Tarbiat Modares University, P.O. Box 14115-175, Tehran, Iran.
J Pharm Biomed Anal. 2011 Dec 15;56(5):859-66. doi: 10.1016/j.jpba.2011.07.029. Epub 2011 Jul 29.
Facilitated transport of three β-blocker drugs including atenolol (ATE), betaxolol (BET) and propranolol (PRO) was investigated under electrical field across a supported liquid membrane (SLM) using phosphoric acid derivatives as selective ion carriers, dissolved in 2-nitro phenyl octyl ether (NPOE). In the presence of di-(2-ethylhexyl) phosphate (DEHP) and tris-(2-ethylhexyl) phosphate (TEHP) in the membrane phase, the three β-blockers showed completely different transport behaviors which enabled highly selective separation of the drugs. Each β-blocker migrated from 3 mL of sample solutions, through a thin layer of specific organic solvent immobilized in the pores of a porous hollow fiber, and into a 15 μL acidic aqueous acceptor solution present inside the lumen of the fiber. The influences of fundamental parameters affecting the transport of target drugs including type of ion carrier for selective separation of each drug and its concentration in the membrane phase, extraction voltage, time of transport, pH of donor and acceptor phases, stirring speed of donor phase and salt effect were studied and optimized. After microextraction process, the extracts were analyzed by high-performance liquid chromatography with ultraviolet detection. Under optimal conditions, ATE was selectively extracted from different saliva samples with recovery of 37%, which corresponded to preconcentration factor of 74. A good linearity was achieved for calibration curve with a coefficient of determination higher than 0.997. Limits of detection and intra-day precision (n=3) were less than 2 μg L(-1) and 8.8%, respectively.
在电场作用下,通过支撑液膜(SLM)研究了三种β-受体阻滞剂药物(包括阿替洛尔(ATE)、倍他洛尔(BET)和普萘洛尔(PRO))的传递情况,使用磷酸衍生物作为选择性离子载体,溶解在 2-硝基苯辛基醚(NPOE)中。在膜相存在二(2-乙基己基)磷酸酯(DEHP)和三(2-乙基己基)磷酸酯(TEHP)的情况下,三种β-受体阻滞剂表现出完全不同的传递行为,从而能够高度选择性地分离药物。每种β-受体阻滞剂从 3 mL 的样品溶液中迁移,通过固定在多孔中空纤维孔中的特定有机溶剂薄层,并进入纤维内腔中的 15 μL 酸性水性接受溶液中。研究并优化了影响目标药物传递的基本参数,包括用于每种药物选择性分离的离子载体的类型及其在膜相中的浓度、萃取电压、传递时间、供体和受体相的 pH 值、供体相的搅拌速度和盐效应。在微萃取过程之后,通过高效液相色谱法与紫外检测对提取物进行分析。在最佳条件下,ATE 可以从不同的唾液样品中选择性地提取,回收率为 37%,对应于 74 倍的预浓缩因子。校准曲线的线性关系良好,相关系数高于 0.997。检测限和日内精密度(n=3)均小于 2 μg L(-1) 和 8.8%。